Eton Pharmaceuticals Inc (ETON)
10.75
+0.32
(+3.07%)
USD |
NASDAQ |
Nov 21, 16:00
10.20
-0.55
(-5.12%)
Pre-Market: 08:03
Eton Pharmaceuticals Revenue (Quarterly): 10.32M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 10.32M |
June 30, 2024 | 9.074M |
March 31, 2024 | 7.966M |
December 31, 2023 | 7.313M |
September 30, 2023 | 7.028M |
June 30, 2023 | 12.00M |
March 31, 2023 | 5.304M |
December 31, 2022 | 8.498M |
September 30, 2022 | 3.219M |
June 30, 2022 | 7.358M |
March 31, 2022 | 2.176M |
December 31, 2021 | 6.093M |
Date | Value |
---|---|
September 30, 2021 | 0.775M |
June 30, 2021 | 3.067M |
March 31, 2021 | 11.90M |
December 31, 2020 | 0.081M |
September 30, 2020 | -0.161M |
June 30, 2020 | 0.02M |
March 31, 2020 | 0.099M |
December 31, 2019 | 0.459M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | 0.50M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.161M
Minimum
Sep 2020
12.00M
Maximum
Jun 2023
5.129M
Average
5.698M
Median
Revenue (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 745.74M |
Integra Lifesciences Holdings Corp | 380.83M |
Elutia Inc | 5.922M |
Immuneering Corp | -- |
Journey Medical Corp | 14.63M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 0.627M |
Total Expenses (Quarterly) | 9.815M |
EPS Diluted (Quarterly) | 0.02 |
Enterprise Value | 261.60M |
Gross Profit Margin (Quarterly) | 61.04% |
Profit Margin (Quarterly) | 6.07% |
Earnings Yield | -2.05% |
Normalized Earnings Yield | -2.046 |